Is Dual Therapy as Effective as Triple Therapy Regarding CD4+/CD8+ Ratio Recovery and Improvement of Immune Activation and Inflammation in HIV-infected Patients With Consistent Plasma Viral Load Suppression (Tridual)

Trial Profile

Is Dual Therapy as Effective as Triple Therapy Regarding CD4+/CD8+ Ratio Recovery and Improvement of Immune Activation and Inflammation in HIV-infected Patients With Consistent Plasma Viral Load Suppression (Tridual)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2018

At a glance

  • Drugs Cobicistat/darunavir (Primary) ; Dolutegravir (Primary) ; Lamivudine (Primary) ; Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat
  • Indications HIV infections
  • Focus Pharmacodynamics
  • Acronyms Tridual
  • Most Recent Events

    • 10 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top